Join
Live feed
·
PRReleasevia Quantisnow
Palisade Bio Inc. logo

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn's Disease at New York Academy of Sciences Symposium

ByQuantisnow·Wall Street's wire, on your screen.
PALI· Palisade Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PALI (Palisade Bio Inc.) and more on Quantisnow.